MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2024 All rights reserved. Tickeron Inc.

ALLO Allogene Therapeutics Forecast, Technical & Fundamental Analysis

a developer of allogeneic chimeric antigen receptor therapy

Industry Biotechnology
ALLO
TickeronSetup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View Trends For ALLO
(Try 14 days for Free)
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
ALLO
TickeronSetup
Buy or SellView
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View Trends For ALLO
(Try 14 days for Free)
Ad is loading...
A.I. Advisor
published Earnings

ALLO is expected to report earnings to rise 1.38% to -32 cents per share on February 26

Allogene Therapeutics ALLO Stock Earnings Reports
Q4'24
Est.
$-0.32
Q3'24
Beat
by $0.01
Q2'24
Est.
$-0.35
Q1'24
Beat
by $0.03
Q4'23
Missed
by $0.06
The last earnings report on November 07 showed earnings per share of -31 cents, beating the estimate of -33 cents. With 1.81M shares outstanding, the current market capitalization sits at 434.02M.
A.I. Advisor
published General Information

General Information

a developer of allogeneic chimeric antigen receptor therapy

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
210 East Grand Avenue
Phone
+1 650 457-2700
Employees
233
Web
https://www.allogene.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

ALLO and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ALLO has been loosely correlated with FATE. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ALLO jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALLO
1D Price
Change %
ALLO100%
+0.49%
FATE - ALLO
58%
Loosely correlated
-6.00%
NTLA - ALLO
57%
Loosely correlated
-1.87%
CRSP - ALLO
56%
Loosely correlated
+0.88%
CRBU - ALLO
55%
Loosely correlated
+1.57%
PRME - ALLO
54%
Loosely correlated
-3.00%
More